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BACKGROUND: Approximately 10% of gastric carcinomas are associated with Epstein–Barr virus (EBV). The Inuit in Greenland have a
high incidence of EBV-associated nasopharyngeal carcinoma.
METHODS: We conducted a population-based case–control study comparing gastric carcinomas in Greenland and in Denmark.
RESULTS: The prevalence rate of EBV-associated gastric carcinomas was 8.5% in both populations.
CONCLUSION: The findings of this study argue against a general susceptibility to EBV-associated carcinomas among the Inuit.
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Approximately 8–10% of gastric carcinomas worldwide are
associated with Epstein–Barr virus (EBV) infection, making
gastric carcinomas the most frequent EBV-associated malignancy
(Burgess et al, 2002; Hjalgrim et al, 2008). The involvement of EBV
in gastric carcinomas is based on the specific presence of viral gene
products such as EBV-encoded small RNA (EBER) in tumour cells,
but not in the surrounding non-neoplastic epithelium, and the
presence of clonal EBV in tumour cells. (Shibata and Weiss, 1992;
Imai et al, 1994). However, the precise aetiological role of EBV in
this cancer and the mechanisms leading to EBV infection of the
gastric epithelium are still unknown.
Undifferentiated nasopharyngeal carcinoma (NPC) is rare in
most parts of the world, but is frequent in Southern China, North
Africa and among the Inuit in the Arctic. The association between
EBV and undifferentiated NPC has been known for the last 40
years, and is now firmly established (IARC working group, 1997;
Hjalgrim et al, 2008). A study among the Chinese indicated that
EBV-associated gastric carcinomas are more common in high- as
compared with low-incidence regions of NPC, suggesting that
these share risk factors (Hao et al, 2002). Not only are the
Greenlandic Inuit an NPC high-risk population but they also have
the world’s highest incidence of salivary gland carcinomas, the
majority being of EBV-associated lymphoepithelial carcinoma
type (Hamilton-Dutoit et al, 1991; Friborg et al, 2003). Remark-
ably, the incidence of gastric carcinomas among the Inuit is
increasing in contrast to the pattern seen elsewhere; the reasons for
this increase are unknown (Friborg et al, 2003; Parkin et al, 2005;
Alberts et al, 2006).
To determine whether the proportion of EBV-associated gastric
carcinomas differs in the Inuit compared with that in the Danish
population, we conducted a population-based comparative study
of patients with gastric carcinoma in Greenland and Denmark.
MATERIALS AND METHODS
The proportion of EBV-associated gastric carcinomas in
Greenland and Denmark was examined in a case–control design
using the Danish Cancer Registry (DCR), the Danish Civil
Registration System and the Danish Pathology Database. All
individuals in Denmark and Greenland are registered in the
Civil Registration System (CRS). The CRS was established in
Denmark on 1 April 1968 and in Greenland on 1 June 1972, when
all persons alive and resident were registered and assigned a
unique personal identification number (the person number).
Information on cancer was retrieved from the DCR. Reporting of
cancer cases to the DCR is mandatory in both Greenland and
Denmark, and the coverage of the Cancer Registry in Denmark has
shown to be 95–98% (Storm et al, 1997). Since 1975, the main
source of information in the registry in Greenland has been
notifications from physicians diagnosing and treating cancer
patients, supplemented by the information obtained from pathol-
ogy reports and death certificates. Information in the registry
related to cancer cases in Greenland before 1975 was obtained
from a study based on review of patient records from all hospitals
in Greenland (Nielsen, 1986; Storm et al, 1997). The proportion
of cases based on histological verification during the period
1973–1997 was 93 and 85% in Denmark and Greenland,
respectively (Friborg et al, 2003).
All gastric carcinomas diagnosed during the period 1973–2002
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Danish Pathology Database, and tumour material was identified in
117 and frequency matched with gastric carcinomas in individuals
born in Denmark. For every Greenlandic case, the Danish gastric
carcinomas of equivalent gender, age (10-year interval) and year of
diagnosis (5-year interval) were identified using the Danish Civil
Registry System and the Danish Cancer Register. All these
potential controls were listed on the basis of a random number,
and the first number was selected as the control. To reduce logistic
effort, Danish controls 440 years of age were recruited from
Aarhus County (B650000 inhabitants), whereas controls below 40
years were collected from all over Denmark (B5.2 million
inhabitants). Paraffin-embedded tumour material was retrieved
from pathology archives in 106 of 117 (90.6%) Greenlandic cases
and in 106 of 117 Danish controls, thus collecting a total of 212
samples for analysis. Of the remaining 22 samples, 12 could not be
traced (5 cases and 7 controls), 4 were unsuitable for EBV analysis
due to lack of tissue (3 cases and 1 control), 4 were excluded due to
a non-gastric carcinoma diagnosis (2 cases and 2 controls) and in 2
cases only tumour material from metastases was available (1 case
and 1 control).
All cases were reclassified by expert histopathologists
according to the WHO 2000 guideline for the diagnosis of gastric
carcinomas (International Agency for Research on Cancer (IARC),
2000), sub-classified according to the Laure ´n classification and
re-staged (pTNM). The pathologist was blinded to EBV status
and country of origin. From the results of the original pathology
report, the macroscopic location of the tumours was determined
as proximal (proximal 2/3 of the stomach), distal (distal 1/3) or
diffuse. Gastric carcinoma cells in paraffin sections were analysed
for the presence of EBV-latent membrane protein-1 and
EBERs using immunohistochemistry with antibody cocktail CS
1–4 (Dako, Glostrup, Denmark) and RNA in situ hybridisation
using the INFORM EBER probe (Ventana Medical Systems,
Illkirch, France), respectively, as described (Zhou et al, 2001) with
modifications. EBV-positive tonsils with infectious mononucleosis
and lymph nodes with Hodgkin’s lymphoma were used as positive
controls. These methods represent the ‘gold standard’ for EBV
analysis in tissue sections, and can be expected to detect the
majority of virally infected tumours, even in archive paraffin
blocks.
The associations between tumour characteristics, and ethnicity
and EBV status were evaluated by P-values obtained from logistic
regression. Adjustments were made for sex, age (10-year interval)
and year at diagnosis (5-year interval). Trend tests for variables
with ordered categories were conducted by assigning the values 1,
2 and 3 to the ordered categories and by treating the variables as
numerical in the regression analyses. A variation in the association
between EBV-associated gastric carcinomas and ethnicity accord-
ing to birth year was evaluated by tests for interaction. Significance
level was set at 0.05.
The study was approved by the Danish data protection board
and by the appropriate scientific ethical committees in both
countries.
RESULTS
We examined 212 gastric carcinomas, 106 from Greenland and 106
from Denmark, respectively, from 135 men (64%) and 77 women
(36%). The average age at diagnosis was 55.1 (range: 26–78) years
among the Inuit and 55.8 (range: 22–79) years among the matched
Danes (Table 1). In both populations, the frequency of EBV-
associated gastric carcinomas was 8.5% (9 of 106) (Table 2),
representing an odds ratio (OR) of 1.0 (CI: 0.4–2.7). EBV-
associated gastric carcinomas were more common among men
(15 of 135¼11.1%) compared with women (3 of 77¼3.9%),
Table 1 The study population
Inuit N¼106 Danes N¼106
Age at diagnosis (range) 55.1 (26–78) 55.8 (22–79)
Males/females 68/38 67/39
EBV positive (%) 8.5 8.5
EBV¼Epstein–Barr virus.
Table 2 Tumour characteristics of gastric carcinomas according to
ethnicity
Inuit n¼106 Danes n¼106
N % N % P-value
EBV status 0.99
EBV-positive gastric carcinoma 9 8.5 9 8.5
EBV-negative gastric carcinoma 97 91.5 97 91.5
Material 0.48
Biopsy 42 39.6 38 35.8
Gastrectomy specimens 64 60.4 68 64.2
Location 0.005
a
Proximal 25 23.6 40 37.7
Distal 55 51.9 37 34.9
Diffuse 5 4.7 11 10.4
Unknown 21 19.8 18 17.0
Histology (WHO) 0.24
b
Papillary 3 2.8 3 2.8
Tubular 71 67.0 63 59.4
Mucinous 4 3.8 1 0.9
Signet-ring cell 20 18.9 25 23.6
Undifferentiated 7 6.6 13 12.3
Adenosquamous 1 0.9 1 0.9
Histology (Laure ´n) 0.27
c
Intestinal 72 67.9 67 63.2
Diffuse 31 29.2 39 36.8
Mixed 3 2.8 0 0
Differentiation of tubular type carcinomas 0.25
d
Good 11 15.5 6 9.5
Moderate 37 52.1 31 49.2
Poor 23 32.4 26 41.2
Degree of lymphocyte infiltration 0.07
d
Low 54 50.9 65 61.3
Moderate 46 43.4 38 35.8
Abundant 6 5.7 3 2.8
Pattern of lymphocyte infiltration 0.99
e
Lymphoepithelioma-like 0 0 0 0
Nodular 22 20.7 22 20.7
Diffuse 80 75.5 84 79.2
Follicular infiltration 4 3.8 0 0
EBV¼Epstein–Barr virus; WHO¼World Health Organisation. Tubular adenocar-
cinomas were categorised as well differentiated (well-formed glands), moderately
differentiated (intermediate between well differentiated and poorly differentiated)
and poorly differentiated (highly irregular glands that are recognised with difficulty or
single cells that remain isolated or are arranged in small clusters) according to WHO
2000. The pattern and degree of lymphocytic infiltration was assessed semi-
quantitatively as either absent, mild, moderate or abundant infiltration by examining
10 medium power fields ( 200 magnification). The pattern of lymphocyte
infiltration was determined as lymphoepithelioma-like, nodular, diffuse or follicular.
aNon-distal vs distal location, samples with ‘unknown’ location not included.
bTubular
histology vs other types.
cSamples with ‘mixed’ histology not included.
dP-value
represents trend test.
eNodular infiltration vs other types.
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between tumour characteristics, and ethnicity and EBV status are
summarised in Tables 2 and 3. The EBV status was not associated
with tumour location, but a distal location was more frequent
among the Inuit (P¼0.005; OR¼0.40; CI: 0.21–0.76). Although
the degree of lymphocytic infiltration was most frequently ‘low’
(119 of 212), it was significantly higher in EBV-associated gastric
carcinomas than in non-EBV-associated gastric carcinomas
(P¼0.03; OR 2.36; CI 1.07–5.22). Tumour histology (WHO/
Laure ´n) was not related to EBV status or ethnicity. Although
undifferentiated gastric carcinomas were identified in patients
from both Greenland and Denmark, none were of the lymphoe-
pithelial type. We observed no temporal changes in either the
proportion of EBV-GC or in the tumour location over the period
(data not shown). The risk of having EBV-associated gastric
carcinomas was not related to ethnicity; but the Inuit with EBV-
positive cases were born earlier than the Danes with such tumours
(Po0.01) (data not shown).
DISCUSSION
We found an equal proportion of EBV-associated gastric
carcinomas in the Inuit and Danes, suggesting that the factors
responsible for the high incidence of EBV-positive NPC and
salivary gland carcinoma in Greenland do not influence the risk of
EBV-associated gastric carcinomas.
The risk of NPC and salivary gland carcinoma are strikingly
higher among the Inuit in Greenland compared with the Danes in
Denmark, with standardised incidence ratios of B35 and 6,
respectively (Friborg et al, 2003). There is also a clear increased
familial risk of NPC and salivary gland carcinoma among the
Inuit, with an eight-fold increased risk in first-degree relatives,
which is among the highest reported for any cancer (Goldgar et al,
1994; Friborg et al, 2005). These high risks imply the existence of
strong genetic or environmental risk factors for EBV-associated
NPC and salivary gland carcinoma in the Inuit population.
However, the similar proportion of EBV-associated gastric
carcinomas in Greenland and Denmark argues against a general
susceptibility to EBV-associated carcinomas among the Inuit.
EBV-associated carcinomas of the nasopharynx and salivary
glands in the Inuit are mainly of the lymphoepithelial type
(Nielsen, 1986). It must be noted that, we did not identify an
increased incidence of gastric carcinomas of this histopathological
type in Greenland.
The proportion of EBV-associated gastric carcinomas in
Greenland and Denmark (8.5%) is comparable with frequencies
found worldwide (IARC working group, 1997; Burgess et al, 2002;
Hjalgrim et al, 2008). Studies of EBV positivity in gastric
carcinomas have produced varied results, with prevalence ranging
from 2 to 15%. Some of this variation may be attributed to
differences in sample collection and EBV detection. The advan-
tages of our study include a population-based case collection, and
optimal, uniform methods for EBV detection.
We did not find an increased proportion of EBV-associated
gastric carcinomas in Greenland, a high-incidence region for other
EBV-associated carcinomas, arguing against a general suscept-
ibility to EBV-associated carcinomas among the Inuit.
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Table 3 Tumour characteristics of gastric carcinoma according to
EBV status
EBV-positive
gastric carcinoma
n¼18
EBV-negative
gastric carcinoma
n¼194
N % N % P-value
Gender 0.19
Males 15 83 120 62
Females 3 17 74 38
Material 0.98
Biopsy 8 44.4 72 37.1
Gastrectomy specimens 10 55.6 122 62.9
Location 0.33
a
Proximal 6 33.3 59 30.4
Distal 6 33.3 86 44.3
Diffuse 2 11.1 14 7.2
Unknown 4 22.2 35 18.0
Histology (WHO) 0.12
b
Papillary 0 0 6 3.1
Tubular 15 83.3 119 61.3
Mucinous 0 0 5 2.6
Signet-ring cell 1 5.6 44 22.7
Undifferentiated 2 11.1 18 9.3
Adenosquamous 0 0 2 1.0
Histology (Laure ´n) 0.23
c
Intestinal 14 77.8 125 64.4
Diffuse 3 16.7 67 34.5
Mixed 1 5.6 2 1.0
Differentiation of tubular
type carcinomas
0.24
d
Good 0 0 17 14.3
Moderate 9 60.0 59 49.6
Poor 6 40.0 43 36.1
Degree of lymphocyte
infiltration
0.03
d
Low 6 33.3 113 58.2
Moderate 9 50.0 75 38.7
Abundant 3 16.7 6 3.1
Pattern of lymphocyte
infiltration
0.60
e
Lymphoepithelioma-like 0 0 0 0
Nodular 3 16.7 41 21.1
Diffuse 15 83.3 149 76.8
Follicular infiltration 0 0 4 2.1
EBV¼Epstein–Barr virus; WHO¼World Health Organisation; Tubular adenocar-
cinomas were categorised as well differentiated (well-formed glands), moderately
differentiated (intermediate between well differentiated and poorly differentiated)
and poorly differentiated (highly irregular glands that are recognised with difficulty or
single cells that remain isolated or are arranged in small clusters) according to WHO
2000. The pattern and degree of lymphocytic infiltration was assessed semi-
quantitatively as absent, mild, moderate or abundant infiltration by examining 10
medium power fields ( 200 magnification). The pattern of lymphocyte infiltration
was determined as lymphoepithelioma-like, nodular, diffuse or follicular.
aNon-distal
vs distal location, samples with ‘unknown’ location not included.
bTubular histology vs
other types.
cSamples with ‘mixed’ histology not included.
dP-value represents trend
test.
eNodular infiltration vs other types.
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